Mario Cooper
Biographic Data
| ID | 8662696 |
|---|---|
| NAME | Mario Cooper |
| GIVEN NAMES | Mario |
| FAMILY NAME | Cooper |
| SIGNATURE | COOPER M |
| AFFILIATIONS | Global Communities CHF, Tegucigalpa, Honduras |
| ORCID | 0009-0003-1612-5529 |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 1974 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Clinical and Epidemiological Profile of Dolutegravir Use and Antiretroviral Resistance in Honduras
Comprehensive care services (SAIs) play a pivotal role in implementing preventive strategies by offering treatments that have demonstrated efficacy, as exemplified by dolutegravir (DTG). This medication has been employed in various clinical settings because of its pronounced genetic barrier and high tolerance. To characterize the clinical and epidemiological use of dolutegravir in people living with HIV (PLHIV) treated for SAI in Honduras. Cross-…
Suppressor Activity in Mice Tolerant of Hemocyanin
No prominent works on this page.
Suppressor Activity in Mice Tolerant of Hemocyanin
Clinical and Epidemiological Profile of Dolutegravir Use and Antiretroviral Resistance in Honduras
Comprehensive care services (SAIs) play a pivotal role in implementing preventive strategies by offering treatments that have demonstrated efficacy, as exemplified by dolutegravir (DTG). This medication has been employed in various clinical settings because of its pronounced genetic barrier and high tolerance. To characterize the clinical and epidemiological use of dolutegravir in people living with HIV (PLHIV) treated for SAI in Honduras. Cross-…
Adoptive cell transfer (1 work) · Antibody (1 work) · Biology (1 work) · Cell Biology (1 work) · Clinical trial (1 work) · Clonal deletion (1 work) · Confidence interval (1 work) · Dolutegravir (1 work) · Epidemiology (1 work) · Erythrocyte Function and Pathophysiology (1 work)